Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
2,493,881
-
Shares change
-
+47,795
-
Total reported value, excl. options
-
$5,085,134
-
Value change
-
-$58,440
-
Put/Call ratio
-
233%
-
Number of buys
-
13
-
Number of sells
-
-10
-
Price
-
$2.04
Significant Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q4 2021
37 filings reported holding BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share as of Q4 2021.
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,493,881 shares
of 2,048,819,940 outstanding shares and own 0.12% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (1,059,722 shares), Parkman Healthcare Partners LLC (428,607 shares), MORGAN STANLEY (260,166 shares), PVG ASSET MANAGEMENT CORP (160,360 shares), ENVESTNET ASSET MANAGEMENT INC (122,224 shares), LPL Financial LLC (73,576 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (70,255 shares), Jump Financial, LLC (33,900 shares), GEODE CAPITAL MANAGEMENT, LLC (32,026 shares), and Geneos Wealth Management Inc. (28,950 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.